|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/505 | |
| A61P 35/00 | |||
| G01N 33/50 |
| (11) | Number of the document | 2205242 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08799418.2 |
| Date of filing the European patent application | 2008-09-10 | |
| (97) | Date of publication of the European application | 2010-07-14 |
| (45) | Date of publication and mention of the grant of the patent | 2015-04-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/075883 |
| Date | 2008-09-10 |
| (87) | Number | WO 2009/036082 |
| Date | 2009-03-19 |
| (30) | Number | Date | Country code |
| 971773 P | 2007-09-12 | US |
| (72) |
BELVIN, Marcia, US
HOEFLICH, Klaus, US
SAMPATH, Deepak, US
VIJAPURKAR, Ulka, US
WALLIN, Jeffrey, US
JOHNSON, Leisa, US
SINGH, Mallika, US
PATEL, Sonal, GB
FRIEDMAN, Lori, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstra e 124, 4070 Basel,
CH
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080-4990, US |
| (54) | COMBINATIONS OF PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE |
| COMBINATIONS OF PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE |